Summit Securities Group’s Replimune Group REPL Stock Holding History

Summit Securities Group’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.28K	Buy	+550	New	+$6.96K	﹤0.01%	831

Other funds holding REPL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Summit Securities Group's REPL Position: Q3 2026 in Review

Summit Securities Group opened a new position in Replimune Group (REPL) in Q3 2026: 550 shares worth $7.28K. The stake represents ﹤0.01% of the portfolio and ranks #831 among its holdings.

91 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

Summit Securities Group held 550 shares of Replimune Group worth $7.28K as of Q3 2026.
Replimune Group was a new Summit Securities Group position in Q3 2026.
Replimune Group made up ﹤0.01% of Summit Securities Group's portfolio in Q3 2026, its #831 holding.
91 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.